Michelson Diagnostics secures financing

Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography technology has closed its Series A2 Financing. The round raised 1.98 million pounds ($3.25million) from existing investors, led by Octopus Investments and supported by Catapult Venture Managers Ltd and London Business Angels and several business angels.

13 January 2014•6 mins read
Feature image
LinkedInXEmail
LinkedInXEmail